hugoapariciomd Profile Banner
Hugo J. Aparicio, MD, MPH, FAHA Profile
Hugo J. Aparicio, MD, MPH, FAHA

@hugoapariciomd

Followers
819
Following
2K
Media
28
Statuses
371

Stroke neurologist @BUMedicine @The_BMC. Brain health, cognition/dementia, biomarkers research @framinghamstudy, VHA, Black Women’s Health Study

Boston, MA
Joined June 2017
Don't wanna be here? Send us removal request.
@StrokeAHA_ASA
Stroke AHA/ASA
4 months
Poststroke Cognitive Decline Across Stroke Types and Ischemic Subtypes In this #BloggingStroke post, @kharsimran14 discusses #Stroke article by Levine et al. #AHAJournals https://t.co/w6YipKfHaX @MitchElkind @profhayward @ST_Pendlebury @hugoapariciomd
Tweet card summary image
ahajournals.org
0
4
13
@StrokeAHA_ASA
Stroke AHA/ASA
6 months
#Stroke risk is elevated among Black women with gestational diabetes mellitus who progress to type 2 diabetes mellitus. @hugoapariciomd #AHAJournals https://t.co/nqDLDP6Hs0
0
1
1
@hugoapariciomd
Hugo J. Aparicio, MD, MPH, FAHA
6 months
"Racial and Ethnic Disparities in Stroke Incidence and Outcomes" published @SpringerNature in Current Cardiovascular Risk Reports. Link to view the article here (and in bio): https://t.co/RktjwPUNip @AnjailIbrahim @Lskolarus @MitchElkind @sudha_md @AmyTowfighiMD @EricaJones_MD
0
0
5
@StrokeAHA_ASA
Stroke AHA/ASA
7 months
🧵#STROKE April Highlights are here: 🌟Cognitive decline became evident 10–13 years poststroke, emphasizing the long-term nature of stroke-related neurocognitive changes and vascular risk management poststroke. @MitchElkind @profhayward @ST_Pendlebury @hugoapariciomd @sudha_md
1
4
8
@AHAScience
AHA Science
10 months
This advisory discusses amyloid-related imaging abnormalities in ppl receiving antibodies directed at the amyloid-beta peptide for treatment of early-stage Alzheimer’s & safety issues related to treatment ✍🏼 @hugoapariciomd @HinmanLabUCLA @MarielKozberg @SMGreenbergNeur @msgoyal
2
14
23
@StrokeAHA_ASA
Stroke AHA/ASA
1 year
Genetic Association Study of Recurrent Cardiovascular Events Strengthens the Role of Inflammation in Ischemic Stroke In this #BloggingStroke post, @B_Rioux discusses #Stroke article by Elmore & Adhikari et al. #AHAJournals https://t.co/PItfoRlgcg
2
2
9
@AHAScience
AHA Science
1 year
This AHA scientific statement discusses the pathogenic mechanisms that link three prevalent cardiac diseases of adults: ➡️Heart failure ➡️Atrial fibrillation ➡️Coronary heart disease These are three disorders that can lead to cognitive impairment and poor brain health.
2
46
97
@canela_news
canelanews
1 year
Cada segundo cuenta: así debemos actuar ante un derrame cerebral. Albania Hernández Sandoval @Albania_Hs y el Doctor Hugo Aparicio @hugoapariciomd, neurólogo de la American Heart Association @American_Heart, nos brindan más información. Recuerda que para #VivirBien tu salud
0
2
5
@tmadsenem
Tracy Madsen MD PhD
1 year
Interested in helping us advance knowledge of sex differences in the epidemiology and mechanisms of cerebrovascular and cardiometabolic disease? My new lab at the University of Vermont @uvmemergencymed @uvmlarnermed is hiring! https://t.co/DWZvZIVv7N @UVMHeartBrain #sexmatters
0
2
4
@tmadsenem
Tracy Madsen MD PhD
1 year
Hot off the presses - @ReginaRoyan et al (@brainstamm, T. Lin, J. Baird, C. Becker, @DrKarb, T. Burton, @dkleindo, S. Prabhakaran, @tmadsenem ) Black stroke patients w/longer time to arrival and less likely to get EMS pre-notification.
Tweet card summary image
ahajournals.org
BACKGROUND: Disparities in time to hospital presentation and prehospital stroke care may be important drivers in inequities in acute stroke treatment rates, functional outcomes, and mortality. It is...
0
4
5
@sudha_md
Sudha Seshadri, MD
1 year
A genome‐wide association meta‐analysis of all‐cause and vascular dementia - Fongang - Alzheimer's & Dementia - Wiley Online Library 🙏🙏👏wonderful collaboration!!
Tweet card summary image
alz-journals.onlinelibrary.wiley.com
INTRODUCTION Dementia is a multifactorial disease with Alzheimer's disease (AD) and vascular dementia (VaD) pathologies making the largest contributions. Yet, most genome-wide association studies...
1
9
39
@hugoapariciomd
Hugo J. Aparicio, MD, MPH, FAHA
1 year
Thank you for the invitation to speak to the faculty and students. It was wonderful to get to hear about all the diverse neurosciences research going on at @MonashSTM and thank you @AmyBrodtmann for hosting me!
@STMneurosci
Monash STM Neuroscience
1 year
Today we had an amazing overview on biomarkers, risk scores and consortiums from @hugoapariciomd of vascular contributions to cognitive impairment and #dementia - its not just good to monitor blood pressure in older age groups but earlier so 40s & 50s - thank you Hugo! 👏🧠
1
3
15
@hugoapariciomd
Hugo J. Aparicio, MD, MPH, FAHA
1 year
@American_Heart @kejoynt @MitchElkind @bweitten @ErinMichos @paheidenreich @CircAHA @PowellWileyLab @texhern @kardiologykazi - There are deep health inequities among BIPOC communities, targeted and sustained interventions are needed - Aging of the pop. will require new approaches to care, and a sufficient workforce End thread
0
0
1
@hugoapariciomd
Hugo J. Aparicio, MD, MPH, FAHA
1 year
@American_Heart @kejoynt @MitchElkind @bweitten @ErinMichos @paheidenreich @CircAHA @PowellWileyLab @texhern @kardiologykazi Individual and public health approaches will be critical to avoid or mitigate these forecasts: - Reductions in vascular risk factors can stem this tide of #heartdisease and #stroke - Early life, “primordial” prevention needs to be a focus
1
0
2
@hugoapariciomd
Hugo J. Aparicio, MD, MPH, FAHA
1 year
@American_Heart @kejoynt @MitchElkind @bweitten @ErinMichos @paheidenreich @CircAHA @PowellWileyLab @texhern @kardiologykazi #Stroke will be a major driver of increased costs, jumping 535% from $67 billion to $423 billion “Forecasting the Economic Burden of CVD and Stroke in the US through 2050” @American_Heart Presidential Advisory https://t.co/dupfBHd0qh
1
0
0
@hugoapariciomd
Hugo J. Aparicio, MD, MPH, FAHA
1 year
@American_Heart @kejoynt @MitchElkind @bweitten @ErinMichos @paheidenreich @CircAHA @PowellWileyLab @texhern @kardiologykazi Much of this we forecast will be due to changing demographics in the US: an aging population, more older adults living with vascular risk factors and #CVD, greater diversification w/ individuals from historically underserved/disenfranchised populations (with higher burden of CVD)
1
0
0
@hugoapariciomd
Hugo J. Aparicio, MD, MPH, FAHA
1 year
1
0
0
@hugoapariciomd
Hugo J. Aparicio, MD, MPH, FAHA
1 year
#Stroke will see the largest increase in prevalence from 2020 to 2050, from 3.9% to 6.4%, with total prevalence number nearly 2x from 10 million to almost 20 million adults “Forecasting the Burden of CVD and Stroke in the US through 2050” AHA Advisory https://t.co/fmc3x5oeVH
1
2
15